The caspases-dependent apoptosis of hepatoma cells induced by an acid-soluble polysaccharide from Grifola frondosa

Juan Yu,Chao Liu,Hai-Yu Ji,An-Jun Liu,Hai-yu Ji,An-jun Liu
DOI: https://doi.org/10.1016/j.ijbiomac.2020.05.095
IF: 8.2
2020-09-01
International Journal of Biological Macromolecules
Abstract:<p>The edible mushroom <em>Grifola frondosa</em> has been used as a functional food for diseases prevention and therapy in Asian countries. In the present work, an acid-soluble polysaccharide (GFAP) was prepared from <em>Grifola frondosa</em> under room temperature and hydrochloric acid solution treatment, and its inhibitory effects on H22 and HepG2 cells were investigated. Results of MTT indicated that GFAP could effectively suppress proliferations of HCC cells, dose-dependently. Microscopic observation results demonstrated that GFAP-treated HCC cells showed apoptotic characteristics like membrane blebbing, chromatin condensed, nucleus pycnosis and fragmentation. Annexin V-FITC/PI staining and cell cycle distribution results showed that GFAP could induce the apoptosis of H22 and HepG2 cells via arresting them in G1 and S phases respectively. Rh123, JC-1 staining and western blotting results suggested that GFAP could significantly increase the permeability of mitochondrial membrane of HCC cells, and upregulated the expressions of Bax, cytochrome <em>c</em>, cleaved-caspase-3 and cleaved-caspase-9, which indicated that GFAP could trigger apoptosis of HCC cells through mitochondria apoptotic pathway in a caspases-dependent pattern. Our data demonstrated that GFAP holds great application prospect as a safe and effective antitumor drug for hepatocellular carcinoma therapy.</p>
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?
This paper aims to explore the anti - tumor effect and its molecular mechanism of an acid - soluble polysaccharide (GFAP) extracted from Grifola frondosa on liver cancer cells (H22 and HepG2 cells). Specifically, the researchers verified whether GFAP could inhibit the proliferation of liver cancer cells through a variety of experimental methods, and further explored the specific pathways of its induction of apoptosis. The study found that GFAP could significantly inhibit the proliferation of H22 and HepG2 cells, and this inhibitory effect was dose - dependent. In addition, GFAP could also induce apoptosis in liver cancer cells by changing the cell cycle distribution, increasing the mitochondrial membrane permeability, up - regulating the expression of the pro - apoptotic protein Bax, down - regulating the expression of the anti - apoptotic protein Bcl - 2, promoting the release of cytochrome c, and activating Caspase - 3 and Caspase - 9. These results indicate that GFAP may play its anti - tumor role through the mitochondrial - mediated endogenous apoptosis pathway. The main purpose of the paper is to provide a theoretical basis for the development of a safe and effective anti - liver - cancer drug or dietary supplement.